Proteome Analysis Identified the PPARγ Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction
- 2 July 2013
- book chapter
- Published by Springer Nature
- p. 101-141
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cellsJournal of Proteomics, 2012
- The Transcription Factor SOX18 Regulates the Expression of Matrix Metalloproteinase 7 and Guidance Molecules in Human Endothelial CellsPLOS ONE, 2012
- 3,3′,4,4′,5,5′-Hexahydroxystilbene Impairs Melanoma Progression in a Metastatic Mouse ModelJournal of Investigative Dermatology, 2010
- Peroxisome proliferator-activated receptor γ agonists inhibit the proliferation and invasion of human colon cancer cellsPostgraduate Medical Journal, 2007
- PPAR-γ ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cellsCancer Letters, 2006
- Effects of 15d-PGJ2 on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cellsProstaglandins & Other Lipid Mediators, 2006
- PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomasJournal of Cancer Research and Clinical Oncology, 2005
- PPAR activators inhibit endothelial cell migration by targeting AktBiochemical and Biophysical Research Communications, 2002
- The Hallmarks of CancerCell, 2000
- Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte DifferentiationNew England Journal of Medicine, 1998